<DOC>
	<DOCNO>NCT02327728</DOCNO>
	<brief_summary>To evaluate efficacy different botulinum toxin A injection pattern treat benign essential blepharospasm compare influence condition eye surface .</brief_summary>
	<brief_title>Comparison Different Botulinum Toxin A Injection Patterns Treatment Blepharospasm</brief_title>
	<detailed_description>The author perform prospective double-blinded randomised clinical trial 60 patient establish diagnosis benign essential blepharospasm February 2013 December 2015 . Patients receive full injection pattern 5 sit one eye medial lower eyelid waived injection pattern 4 site eye randomly . They survey ocular surface disease index ( OSDI ) , Jankovic rating scale ( JRS ) , blepharospasm disability index ( BSDI ) prior injection 1week , 1month 3 month injection . At time point , closure eyelid , tear break time ( BUT ) , Schirmer test ï¼© , low lid tear meniscus height ( TMH ) also measure .</detailed_description>
	<mesh_term>Blepharospasm</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>confirm diagnosis bilateral BEB minimum 24week period since last injection require patient previously receive multiple injection BoNTA . blepharospasm know etiology ( caused medication , injury , etc . ) history surgical intervention BEB ( myectomy neurectomy ) current ophthalmologic infection apraxia eyelid opening associate levator palpebrae dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>blepharospasm</keyword>
	<keyword>botulinum A</keyword>
	<keyword>injection pattern</keyword>
	<keyword>tear</keyword>
</DOC>